Retraction: Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites

Abstract

Retraction of ‘Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites’ by Maorong Wang et al., RSC Adv., 2020, 10, 8044–8053, DOI: https://doi.org/10.1039/C9RA10593J.